HONG KONG– A newly discovered human monoclonal antibody (MAb) that can neutralize several different types of influenza A virus may represent a new antiviral treatment and potentially lead to the development of new more potent vaccines, according to a Chinese study reported in the July 21, 2015, issue of Nature Communications. Read More
HONG KONG – The CFDA is getting closer to completing a new revision of the country's Pharmaceutical Administration Law. After drastically increasing the registration fees for pharmaceuticals this year, the CFDA is now soliciting opinions on a draft guideline for the registration inspection of imported pharmaceutical products. Read More
HONG KONG – The discovery by Japanese researchers of a single nucleotide polymorphism (SNP) in a gene linked to increased susceptibility to adolescent idiopathic scoliosis (AIS), could lead to the identification of new therapeutic targets for this common and currently incurable condition. Read More
Researchers from the Korean Seoul National University and Yonsei University School of Medicine have used the CRISPR/Cas9 editing system to correct a hemophilia gene in induced pluripotent stem cells (iPSCs) and showed that such cells enabled mice with an otherwise lethal form of hemophilia A to survive. Read More
Mesoblast Ltd., of Melbourne, Australia, said results of a phase II trial of intravenously delivered mesenchymal precursor cells (MPCs) for the treatment of type 2 diabetes, published in Diabetes Care, showed that a single MPC infusion, ranging from 0.3 to 2 million MPCs/kg, was safe and well tolerated. Read More
Novogen Ltd., of Sydney, appointed Iain Ross to its board and named him acting CEO. Ross is currently chairman of Premier Veterinary Group plc (formerly Ark Therapeutics plc). Read More
TAIPEI, Taiwan – China's fast-growing health care sector presents excellent opportunities for industry collaboration for overseas companies. And Taiwan, with its existing cultural, language and business ties with China, is particularly well placed to take advantage of those conditions. Read More
